A nationwide recall of fentanyl transdermal patches has been issued by Alvogen Inc., raising serious safety warnings. The recall, affecting one lot of 25 mcg/h patches with lot number 108319, comes after concerns that improperly manufactured patches could be “multi-stacked” within a single pouch. Such defects pose life-threatening risks, especially for vulnerable groups like first-time users, children, and the elderly.
Fentanyl, a potent opioid designed for managing severe pain, has come under increased scrutiny due to its role in addiction and overdose crises. While it is meant to be used under strict medical supervision, misuse or accidental exposure can lead to fatal respiratory depression. The recall announcement highlights the growing need for increased vigilance in handling and disposing of such dangerous substances.
According to the U.S. Food and Drug Administration (FDA), any affected patches currently in use must be removed and patients are instructed to consult their health care provider. For safe disposal, the FDA advises folding used patches with the adhesive sides together and flushing them to prevent accidental exposure.
This latest recall sheds light on the broader challenges posed by opioids, emphasising the vital importance of safety measures to circumvent the risk of dependence and the increasing dangers of improper drug management. Public health solutions must focus on eliminating these threats to protect individuals and communities from such hazardous substances.
Source: Newsweek
Leave a Reply